(Q47348407)

14 January 2018

title

Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant (English)

1 reference

14 January 2018

main subject

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

4

Philippe Langella

1 reference

14 January 2018

author name string

Naima G Cortes-Perez

1

1 reference

14 January 2018

Luis F da Costa Medina

2

1 reference

14 January 2018

François Lefèvre

3

1 reference

14 January 2018

Luis G Bermúdez-Humarán

5

1 reference

14 January 2018

language of work or name

English

0 references

publication date

13 September 2008

1 reference

14 January 2018

published in

Vaccine

1 reference

14 January 2018

volume

26

1 reference

14 January 2018

issue

46

1 reference

14 January 2018

page(s)

5778-5783

1 reference

14 January 2018

Lymphocyte traffic control by chemokines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

HuMig: a new human member of the chemokine family of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Mig and IP-10: CXC chemokines that target lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

The biology of chemokines and their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Chemokines: a new classification system and their role in immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Potential and opportunities for use of recombinant lactic acid bacteria in human health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Production of biological active murine IFN-gamma by recombinant Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Production of human papillomavirus type 16 E7 protein in Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

IFN-gamma-inducible chemokines enhance adaptive immunity and colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Modulation of immune responses induced by DNA vaccine expressing glycoprotein B of Pseudorabies Virus via coadministration of IFN-gamma-associated cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Differential segregation of protective immunity by encoded antigen in DNA vaccine against pseudorabies virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Nasal vaccination using live bacterial vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.044

10.1016/J.VACCINE.2008.08.044

7 January 2021

Identifiers

DOI

1 reference

14 January 2018

release_lhx4mikngneongwjuqfrrs2llm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lhx4mikngneongwjuqfrrs2llm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 January 2018